It should have occurred to me that entrenched sector giants like Merck or J & J would prefer to squelch competition in the interest of ramping up profits, and would rather see BIXT remain an obscure, off-the-radar OTC company that can never threaten market share currently monoploized by the behemoths...Sigh...
News 
Market Data 
Discover 
AI
